Based on recent data, Vor Biopharma Inc. (VOR) shows an Average True Range (ATR) of 1.32 and an Enterprise Value of 123M. Its average trading volume over the past 3 months is 1.06M, indicating liquidity. These fundamental metrics provide insight into VOR's underlying financial health and market activity.
| ATR | 1.32 |
| Enterprise Value | 123M |
| Avg Vol (3 Months) | 1.06M |
| Avg Vol (10 Days) | 1.34M |
Vor Biopharma Inc. (VOR) technical indicators as of June 23, 2026: the SMA 20 is 16.8%, SMA 50 at 14.23%, and SMA 200 at -29.37%. The RSI 14 value is 62.31, suggesting its current momentum. These technical analysis signals help assess VOR's price trends and potential future movements.
| SMA 20 | 16.8% |
| SMA 50 | 14.23% |
| SMA 200 | -29.37% |
| RSI 14 | 62.31 |
Vor Biopharma Inc. (VOR) stock performance overview as of June 23, 2026: The 52-week high is $65.8 (currently -75.84% below), and the 52-week low is $5.8 (currently 506.41% above). Over the past year, VOR's performance is -35.29%, compared to the S&P 500's 9.62% change.
| 52-Week High | 65.8 |
| 52-Week High Chg | -75.84% |
| 52-Week Low | 5.8 |
| 52-Week Low Chg | +506.41% |
| S&P 500 52-Week Chg | 9.62% |
According to market data, Vor Biopharma Inc. (VOR) stock's recent performance metrics show that over the last month, VOR is 23.42%, with a Year-to-Date (YTD) performance of 34.56%. Over the past year, the stock has seen a -35.29% change. These figures summarize VOR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 15.44 | 15.59 | 19.7 | 19.7 | 65.8 | 19.7 |
| Low | 13.79 | 12.58 | 11.7 | 8.95 | 5.8 | 10.29 |
| Performance | +24.38% | +23.42% | -39.31% | -57.07% | -35.29% | +34.56% |
According to current financial data, VOR stock's P/E (TTM) ratio is -0.03, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for VOR, including P/S (N/A), P/B (-0.04), and P/FCF (-0.69), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | VOR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.03 | -1.22 | -5.02 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 462.04 | 5.98 |
| P/B (TTM) | -0.04 | 1.8 | 11.65 | 5.04 |
| P/FCF (TTM) | -0.69 | -16.4 | -905.79 | 28.54 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep